...
首页> 外文期刊>Clinical & developmental immunology. >HLA Associations and Clinical Implications in T-Cell Mediated Drug Hypersensitivity Reactions: An Updated Review
【24h】

HLA Associations and Clinical Implications in T-Cell Mediated Drug Hypersensitivity Reactions: An Updated Review

机译:HLA协会和T细胞介导的药物超敏反应的临床意义:最新的审查。

获取原文
获取原文并翻译 | 示例

摘要

T-cell mediated drug hypersensitivity reactions may range from mild rash to severe fatal reactions. Among them, drug reaction with eosinophilia and systemic symptoms (DRESS) or drug-induced hypersensitivity syndrome (DIHS), Stevens-Johnson syndrome/ toxic epidermal necrolysis (SJS/TEN), are some of the most life-threatening severe cutaneous adverse reactions (SCARs). Recent advances in pharmacogenetic studies show strong genetic associations between human leukocyte antigen (HLA) alleles and susceptibility to drug hypersensitivity. This review summarizes the literature on recent progresses in pharmacogenetic studies and clinical application of pharmacogenetic screening based on associations between SCARs and specific HLA alleles to avoid serious conditions associated with drug hypersensitivity.
机译:T细胞介导的药物超敏反应的范围可能从轻度皮疹到严重的致命反应。其中,与嗜酸性粒细胞增多和全身症状(DRESS)或药物引起的超敏反应综合征(DIHS),史蒂文斯-约翰逊综合征/中毒性表皮坏死溶解(SJS / TEN)的药物反应是一些最致命的严重皮肤不良反应(疤痕)。药物遗传学研究的最新进展表明,人白细胞抗原(HLA)等位基因与药物超敏性之间存在密切的遗传联系。这篇综述总结了有关药物遗传学研究和药物遗传学筛选的临床应用的最新进展的文献,这些研究基于SCAR和特定的HLA等位基因之间的关联,以避免与药物超敏反应相关的严重疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号